AstraZeneca, Gilead merger doubted by Wall Street analysts
By Manas Mishra (Reuters) - A merger between AstraZeneca and Gilead Sciences Inc is unlikely due to significant political hurdles, Wall Street analysts said on Monday after a Bloomberg report that the British drugmaker last month had contacted its U.S. rival about a deal.
By Manas Mishra
(Reuters) - A merger between AstraZeneca and Gilead Sciences Inc is unlikely due to significant political hurdles, Wall Street analysts said on Monday after a Bloomberg report that the British drugmaker last month had contacted its U.S. rival about a deal.
Gilead's shares were up marginally in morning trading, paring their earlier gains after CNBC reported, citing sources, that the companies were not in active talks.
Such a merger would unite two drugmakers at the forefront of efforts to fight the new coronavirus , but could be politically sensitive as governments seek control over potential vaccines or treatments.
Gilead, whose drug remdesivir has shown improvement in COVID-19 patients in clinical trials and has been cleared for emergency use in several countries, was not interested in combining with another big drugmaker, Bloomberg reported on Sunday.
"We would be very surprised if ownership of Gilead was permitted to leave the United States," said SVB Leerink analyst Geoffrey Porges.
"Domestic R&D and manufacturing capabilities, particularly in healthcare, have never been more important to the national interest."
Citi analyst Andrew Baum said he anticipated that the U.S. administration would likely seek to block potential acquisitions of any major U.S. biopharma company involved in the development of future therapeutics for the pandemic.
Gilead shares were up 0.6% in mid-day trading after gaining more than 3% earlier in the session.
AstraZeneca's shares closed down 2.7% on the FTSE 100 as investors contemplated a large payout and questioned the rationale of a deal that would create a company with a combined market value of about $232 billion, based on Friday's closing prices.
"We have to admit that even the willingness to consider such a perplexing, and in our view, potentially value-destroying deal sets our nerves on edge," said Guggenheim analyst Seamus Fernandez.
AstraZeneca is developing a vaccine for COVID-19 through its partnership with Oxford University.
This story has not been edited by Firstpost staff and is generated by auto-feed.
By Robin Emmott and John Irish | BRUSSELS/PARIS BRUSSELS/PARIS France and Germany will agree to a U.S. plan for NATO to take a bigger role in the fight against Islamic militants at a meeting with President Donald Trump on Thursday, but insist the move is purely symbolic, four senior European diplomats said.The decision to allow the North Atlantic Treaty Organization to join the coalition against Islamic State in Syria and Iraq follows weeks of pressure on the two allies, who are wary of NATO confronting Russia in Syria and of alienating Arab countries who see NATO as pushing a pro-Western agenda."NATO as an institution will join the coalition," said one senior diplomat involved in the discussions. "The question is whether this just a symbolic gesture to the United States
BEIJING Chinese President Xi Jinping on Wednesday called for greater efforts to make the country's navy a world class one, strong in operations on, below and above the surface, as it steps up its ability to project power far from its shores.China's navy has taken an increasingly prominent role in recent months, with a rising star admiral taking command, its first aircraft carrier sailing around self-ruled Taiwan and a new aircraft carrier launched last month.With President Donald Trump promising a US shipbuilding spree and unnerving Beijing with his unpredictable approach on hot button issues including Taiwan and the South and East China Seas, China is pushing to narrow the gap with the U.S. Navy.Inspecting navy headquarters, Xi said the navy should "aim for the top ranks in the world", the Defence Ministry said in a statement about his visit."Building a strong and modern navy is an important mark of a top ranking global military," the ministry paraphrased Xi as saying.